Private Equity Firm Acquires Majority Interest in LGM Pharma
By

LGM Pharma, an active pharmaceutical ingredient (API) supplier, has received a majority equity investment from New Harbor Capital, a Chicago, Illinois-based private equity firm.

LGM Pharma is involved in the distribution of cGMP pharmaceutical ingredients. It specializes in providing integrated sourcing options, technical capabilities, and regulatory documentation support for a wide range of APIs.

Source: LGM Pharma

Leave a Reply

Your email address will not be published. Required fields are marked *